Stock in Focus: MetLife Inc. (MET)

Company Profile:

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Recent News:

September 17, 2020, the company announced it has entered into a definitive agreement to acquire Versant Health from an investor group led by Centerbridge Partners and including FFL Partners for approximately $1.675 billion in an all-cash transaction.

August 17, 2020, the company has declared the preferred stock dividends. The dividends will be payable Sept. 15, 2020, to shareholders of record as of Aug. 31, 2020.

The company reported net income for the second quarter of 2020 was $68 million, or $0.07 per share, compared to net income of $1.7 billion, or $1.77 per share in the second quarter of 2019.


Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.


Profitability – Measures the historical price movement of the stock.


Solvency – Measures the solvency of the company based on several ratios.


Efficiency – Measures the strength and historic growth of a company’s return on invested capital.



MET’s strengths can be seen in its strong growth, better profitability and robust efficiency compared with its peers. Technical indicators signal the bullish signs, as there is a bullish crossover in MACD and Stochastic oscillator. The RSI stands at 56.82 with positive bias. We rate MetLife Inc. (MET) a STRONG BUY.

About the Author

has written 13073 stories on this site.

Copyright © 2012 Nine Stocks